1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global IV and Oral Iron Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Oral Iron Drug 1.2.3 IVIron Drugs 1.3 Market by Application 1.3.1 Global IV and Oral Iron Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Nephrology 1.3.3 OBGYN 1.3.4 Surgeries 1.3.5 Gastroenterology 1.3.6 Oncology 1.3.7 Heart failure (HF) 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global IV and Oral Iron Drugs Market Perspective (2017-2028) 2.2 IV and Oral Iron Drugs Growth Trends by Region 2.2.1 IV and Oral Iron Drugs Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 IV and Oral Iron Drugs Historic Market Size by Region (2017-2022) 2.2.3 IV and Oral Iron Drugs Forecasted Market Size by Region (2023-2028) 2.3 IV and Oral Iron Drugs Market Dynamics 2.3.1 IV and Oral Iron Drugs Industry Trends 2.3.2 IV and Oral Iron Drugs Market Drivers 2.3.3 IV and Oral Iron Drugs Market Challenges 2.3.4 IV and Oral Iron Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top IV and Oral Iron Drugs Players by Revenue 3.1.1 Global Top IV and Oral Iron Drugs Players by Revenue (2017-2022) 3.1.2 Global IV and Oral Iron Drugs Revenue Market Share by Players (2017-2022) 3.2 Global IV and Oral Iron Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by IV and Oral Iron Drugs Revenue 3.4 Global IV and Oral Iron Drugs Market Concentration Ratio 3.4.1 Global IV and Oral Iron Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by IV and Oral Iron Drugs Revenue in 2021 3.5 IV and Oral Iron Drugs Key Players Head office and Area Served 3.6 Key Players IV and Oral Iron Drugs Product Solution and Service 3.7 Date of Enter into IV and Oral Iron Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 IV and Oral Iron Drugs Breakdown Data by Type 4.1 Global IV and Oral Iron Drugs Historic Market Size by Type (2017-2022) 4.2 Global IV and Oral Iron Drugs Forecasted Market Size by Type (2023-2028) 5 IV and Oral Iron Drugs Breakdown Data by Application 5.1 Global IV and Oral Iron Drugs Historic Market Size by Application (2017-2022) 5.2 Global IV and Oral Iron Drugs Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America IV and Oral Iron Drugs Market Size (2017-2028) 6.2 North America IV and Oral Iron Drugs Market Size by Type 6.2.1 North America IV and Oral Iron Drugs Market Size by Type (2017-2022) 6.2.2 North America IV and Oral Iron Drugs Market Size by Type (2023-2028) 6.2.3 North America IV and Oral Iron Drugs Market Share by Type (2017-2028) 6.3 North America IV and Oral Iron Drugs Market Size by Application 6.3.1 North America IV and Oral Iron Drugs Market Size by Application (2017-2022) 6.3.2 North America IV and Oral Iron Drugs Market Size by Application (2023-2028) 6.3.3 North America IV and Oral Iron Drugs Market Share by Application (2017-2028) 6.4 North America IV and Oral Iron Drugs Market Size by Country 6.4.1 North America IV and Oral Iron Drugs Market Size by Country (2017-2022) 6.4.2 North America IV and Oral Iron Drugs Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe IV and Oral Iron Drugs Market Size (2017-2028) 7.2 Europe IV and Oral Iron Drugs Market Size by Type 7.2.1 Europe IV and Oral Iron Drugs Market Size by Type (2017-2022) 7.2.2 Europe IV and Oral Iron Drugs Market Size by Type (2023-2028) 7.2.3 Europe IV and Oral Iron Drugs Market Share by Type (2017-2028) 7.3 Europe IV and Oral Iron Drugs Market Size by Application 7.3.1 Europe IV and Oral Iron Drugs Market Size by Application (2017-2022) 7.3.2 Europe IV and Oral Iron Drugs Market Size by Application (2023-2028) 7.3.3 Europe IV and Oral Iron Drugs Market Share by Application (2017-2028) 7.4 Europe IV and Oral Iron Drugs Market Size by Country 7.4.1 Europe IV and Oral Iron Drugs Market Size by Country (2017-2022) 7.4.2 Europe IV and Oral Iron Drugs Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific IV and Oral Iron Drugs Market Size (2017-2028) 8.2 Asia-Pacific IV and Oral Iron Drugs Market Size by Type 8.2.1 Asia-Pacific IV and Oral Iron Drugs Market Size by Type (2017-2022) 8.2.2 Asia-Pacific IV and Oral Iron Drugs Market Size by Type (2023-2028) 8.2.3 Asia-Pacific IV and Oral Iron Drugs Market Share by Type (2017-2028) 8.3 Asia-Pacific IV and Oral Iron Drugs Market Size by Application 8.3.1 Asia-Pacific IV and Oral Iron Drugs Market Size by Application (2017-2022) 8.3.2 Asia-Pacific IV and Oral Iron Drugs Market Size by Application (2023-2028) 8.3.3 Asia-Pacific IV and Oral Iron Drugs Market Share by Application (2017-2028) 8.4 Asia-Pacific IV and Oral Iron Drugs Market Size by Region 8.4.1 Asia-Pacific IV and Oral Iron Drugs Market Size by Region (2017-2022) 8.4.2 Asia-Pacific IV and Oral Iron Drugs Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America IV and Oral Iron Drugs Market Size (2017-2028) 9.2 Latin America IV and Oral Iron Drugs Market Size by Type 9.2.1 Latin America IV and Oral Iron Drugs Market Size by Type (2017-2022) 9.2.2 Latin America IV and Oral Iron Drugs Market Size by Type (2023-2028) 9.2.3 Latin America IV and Oral Iron Drugs Market Share by Type (2017-2028) 9.3 Latin America IV and Oral Iron Drugs Market Size by Application 9.3.1 Latin America IV and Oral Iron Drugs Market Size by Application (2017-2022) 9.3.2 Latin America IV and Oral Iron Drugs Market Size by Application (2023-2028) 9.3.3 Latin America IV and Oral Iron Drugs Market Share by Application (2017-2028) 9.4 Latin America IV and Oral Iron Drugs Market Size by Country 9.4.1 Latin America IV and Oral Iron Drugs Market Size by Country (2017-2022) 9.4.2 Latin America IV and Oral Iron Drugs Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa IV and Oral Iron Drugs Market Size (2017-2028) 10.2 Middle East & Africa IV and Oral Iron Drugs Market Size by Type 10.2.1 Middle East & Africa IV and Oral Iron Drugs Market Size by Type (2017-2022) 10.2.2 Middle East & Africa IV and Oral Iron Drugs Market Size by Type (2023-2028) 10.2.3 Middle East & Africa IV and Oral Iron Drugs Market Share by Type (2017-2028) 10.3 Middle East & Africa IV and Oral Iron Drugs Market Size by Application 10.3.1 Middle East & Africa IV and Oral Iron Drugs Market Size by Application (2017-2022) 10.3.2 Middle East & Africa IV and Oral Iron Drugs Market Size by Application (2023-2028) 10.3.3 Middle East & Africa IV and Oral Iron Drugs Market Share by Application (2017-2028) 10.4 Middle East & Africa IV and Oral Iron Drugs Market Size by Country 10.4.1 Middle East & Africa IV and Oral Iron Drugs Market Size by Country (2017-2022) 10.4.2 Middle East & Africa IV and Oral Iron Drugs Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Daiichi Sankyo Company 11.1.1 Daiichi Sankyo Company Company Details 11.1.2 Daiichi Sankyo Company Business Overview 11.1.3 Daiichi Sankyo Company IV and Oral Iron Drugs Introduction 11.1.4 Daiichi Sankyo Company Revenue in IV and Oral Iron Drugs Business (2017-2022) 11.1.5 Daiichi Sankyo Company Recent Developments 11.2 Vifor Pharma 11.2.1 Vifor Pharma Company Details 11.2.2 Vifor Pharma Business Overview 11.2.3 Vifor Pharma IV and Oral Iron Drugs Introduction 11.2.4 Vifor Pharma Revenue in IV and Oral Iron Drugs Business (2017-2022) 11.2.5 Vifor Pharma Recent Developments 11.3 Akebia Therapeutics 11.3.1 Akebia Therapeutics Company Details 11.3.2 Akebia Therapeutics Business Overview 11.3.3 Akebia Therapeutics IV and Oral Iron Drugs Introduction 11.3.4 Akebia Therapeutics Revenue in IV and Oral Iron Drugs Business (2017-2022) 11.3.5 Akebia Therapeutics Recent Developments 11.4 Allergan 11.4.1 Allergan Company Details 11.4.2 Allergan Business Overview 11.4.3 Allergan IV and Oral Iron Drugs Introduction 11.4.4 Allergan Revenue in IV and Oral Iron Drugs Business (2017-2022) 11.4.5 Allergan Recent Developments 11.5 AMAG Pharmaceuticals 11.5.1 AMAG Pharmaceuticals Company Details 11.5.2 AMAG Pharmaceuticals Business Overview 11.5.3 AMAG Pharmaceuticals IV and Oral Iron Drugs Introduction 11.5.4 AMAG Pharmaceuticals Revenue in IV and Oral Iron Drugs Business (2017-2022) 11.5.5 AMAG Pharmaceuticals Recent Developments 11.6 AOP Orphan Pharmaceuticals 11.6.1 AOP Orphan Pharmaceuticals Company Details 11.6.2 AOP Orphan Pharmaceuticals Business Overview 11.6.3 AOP Orphan Pharmaceuticals IV and Oral Iron Drugs Introduction 11.6.4 AOP Orphan Pharmaceuticals Revenue in IV and Oral Iron Drugs Business (2017-2022) 11.6.5 AOP Orphan Pharmaceuticals Recent Developments 11.7 Pharmacosmos 11.7.1 Pharmacosmos Company Details 11.7.2 Pharmacosmos Business Overview 11.7.3 Pharmacosmos IV and Oral Iron Drugs Introduction 11.7.4 Pharmacosmos Revenue in IV and Oral Iron Drugs Business (2017-2022) 11.7.5 Pharmacosmos Recent Developments 11.8 Sanofi 11.8.1 Sanofi Company Details 11.8.2 Sanofi Business Overview 11.8.3 Sanofi IV and Oral Iron Drugs Introduction 11.8.4 Sanofi Revenue in IV and Oral Iron Drugs Business (2017-2022) 11.8.5 Sanofi Recent Developments 11.9 Shield Therapeutics 11.9.1 Shield Therapeutics Company Details 11.9.2 Shield Therapeutics Business Overview 11.9.3 Shield Therapeutics IV and Oral Iron Drugs Introduction 11.9.4 Shield Therapeutics Revenue in IV and Oral Iron Drugs Business (2017-2022) 11.9.5 Shield Therapeutics Recent Developments 11.10 AZAD Pharma 11.10.1 AZAD Pharma Company Details 11.10.2 AZAD Pharma Business Overview 11.10.3 AZAD Pharma IV and Oral Iron Drugs Introduction 11.10.4 AZAD Pharma Revenue in IV and Oral Iron Drugs Business (2017-2022) 11.10.5 AZAD Pharma Recent Developments 11.11 Cirondrugs 11.11.1 Cirondrugs Company Details 11.11.2 Cirondrugs Business Overview 11.11.3 Cirondrugs IV and Oral Iron Drugs Introduction 11.11.4 Cirondrugs Revenue in IV and Oral Iron Drugs Business (2017-2022) 11.11.5 Cirondrugs Recent Developments 11.12 MEDICE 11.12.1 MEDICE Company Details 11.12.2 MEDICE Business Overview 11.12.3 MEDICE IV and Oral Iron Drugs Introduction 11.12.4 MEDICE Revenue in IV and Oral Iron Drugs Business (2017-2022) 11.12.5 MEDICE Recent Developments 11.13 Pfizer 11.13.1 Pfizer Company Details 11.13.2 Pfizer Business Overview 11.13.3 Pfizer IV and Oral Iron Drugs Introduction 11.13.4 Pfizer Revenue in IV and Oral Iron Drugs Business (2017-2022) 11.13.5 Pfizer Recent Developments 11.14 Salveo Lifecare 11.14.1 Salveo Lifecare Company Details 11.14.2 Salveo Lifecare Business Overview 11.14.3 Salveo Lifecare IV and Oral Iron Drugs Introduction 11.14.4 Salveo Lifecare Revenue in IV and Oral Iron Drugs Business (2017-2022) 11.14.5 Salveo Lifecare Recent Developments 11.15 Sunny Pharmaceutical 11.15.1 Sunny Pharmaceutical Company Details 11.15.2 Sunny Pharmaceutical Business Overview 11.15.3 Sunny Pharmaceutical IV and Oral Iron Drugs Introduction 11.15.4 Sunny Pharmaceutical Revenue in IV and Oral Iron Drugs Business (2017-2022) 11.15.5 Sunny Pharmaceutical Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

List of Tables Table 1. Global IV and Oral Iron Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Oral Iron Drug Table 3. Key Players of IVIron Drugs Table 4. Global IV and Oral Iron Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 5. Global IV and Oral Iron Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global IV and Oral Iron Drugs Market Size by Region (2017-2022) & (US$ Million) Table 7. Global IV and Oral Iron Drugs Market Share by Region (2017-2022) Table 8. Global IV and Oral Iron Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global IV and Oral Iron Drugs Market Share by Region (2023-2028) Table 10. IV and Oral Iron Drugs Market Trends Table 11. IV and Oral Iron Drugs Market Drivers Table 12. IV and Oral Iron Drugs Market Challenges Table 13. IV and Oral Iron Drugs Market Restraints Table 14. Global IV and Oral Iron Drugs Revenue by Players (2017-2022) & (US$ Million) Table 15. Global IV and Oral Iron Drugs Revenue Share by Players (2017-2022) Table 16. Global Top IV and Oral Iron Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IV and Oral Iron Drugs as of 2021) Table 17. Ranking of Global Top IV and Oral Iron Drugs Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by IV and Oral Iron Drugs Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players IV and Oral Iron Drugs Product Solution and Service Table 21. Date of Enter into IV and Oral Iron Drugs Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global IV and Oral Iron Drugs Market Size by Type (2017-2022) & (US$ Million) Table 24. Global IV and Oral Iron Drugs Revenue Market Share by Type (2017-2022) Table 25. Global IV and Oral Iron Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global IV and Oral Iron Drugs Revenue Market Share by Type (2023-2028) Table 27. Global IV and Oral Iron Drugs Market Size by Application (2017-2022) & (US$ Million) Table 28. Global IV and Oral Iron Drugs Revenue Share by Application (2017-2022) Table 29. Global IV and Oral Iron Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global IV and Oral Iron Drugs Revenue Share by Application (2023-2028) Table 31. North America IV and Oral Iron Drugs Market Size by Type (2017-2022) & (US$ Million) Table 32. North America IV and Oral Iron Drugs Market Size by Type (2023-2028) & (US$ Million) Table 33. North America IV and Oral Iron Drugs Market Size by Application (2017-2022) & (US$ Million) Table 34. North America IV and Oral Iron Drugs Market Size by Application (2023-2028) & (US$ Million) Table 35. North America IV and Oral Iron Drugs Market Size by Country (2017-2022) & (US$ Million) Table 36. North America IV and Oral Iron Drugs Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe IV and Oral Iron Drugs Market Size by Type (2017-2022) & (US$ Million) Table 38. Europe IV and Oral Iron Drugs Market Size by Type (2023-2028) & (US$ Million) Table 39. Europe IV and Oral Iron Drugs Market Size by Application (2017-2022) & (US$ Million) Table 40. Europe IV and Oral Iron Drugs Market Size by Application (2023-2028) & (US$ Million) Table 41. Europe IV and Oral Iron Drugs Market Size by Country (2017-2022) & (US$ Million) Table 42. Europe IV and Oral Iron Drugs Market Size by Country (2023-2028) & (US$ Million) Table 43. Asia Pacific IV and Oral Iron Drugs Market Size by Type (2017-2022) & (US$ Million) Table 44. Asia Pacific IV and Oral Iron Drugs Market Size by Type (2023-2028) & (US$ Million) Table 45. Asia Pacific IV and Oral Iron Drugs Market Size by Application (2017-2022) & (US$ Million) Table 46. Asia Pacific IV and Oral Iron Drugs Market Size by Application (2023-2028) & (US$ Million) Table 47. Asia Pacific IV and Oral Iron Drugs Market Size by Region (2017-2022) & (US$ Million) Table 48. Asia Pacific IV and Oral Iron Drugs Market Size by Region (2023-2028) & (US$ Million) Table 49. Latin America IV and Oral Iron Drugs Market Size by Type (2017-2022) & (US$ Million) Table 50. Latin America IV and Oral Iron Drugs Market Size by Type (2023-2028) & (US$ Million) Table 51. Latin America IV and Oral Iron Drugs Market Size by Application (2017-2022) & (US$ Million) Table 52. Latin America IV and Oral Iron Drugs Market Size by Application (2023-2028) & (US$ Million) Table 53. Latin America IV and Oral Iron Drugs Market Size by Country (2017-2022) & (US$ Million) Table 54. Latin America IV and Oral Iron Drugs Market Size by Country (2023-2028) & (US$ Million) Table 55. Middle East and Africa IV and Oral Iron Drugs Market Size by Type (2017-2022) & (US$ Million) Table 56. Middle East and Africa IV and Oral Iron Drugs Market Size by Type (2023-2028) & (US$ Million) Table 57. Middle East and Africa IV and Oral Iron Drugs Market Size by Application (2017-2022) & (US$ Million) Table 58. Middle East and Africa IV and Oral Iron Drugs Market Size by Application (2023-2028) & (US$ Million) Table 59. Middle East and Africa IV and Oral Iron Drugs Market Size by Country (2017-2022) & (US$ Million) Table 60. Middle East and Africa IV and Oral Iron Drugs Market Size by Country (2023-2028) & (US$ Million) Table 61. Daiichi Sankyo Company Company Details Table 62. Daiichi Sankyo Company Business Overview Table 63. Daiichi Sankyo Company IV and Oral Iron Drugs Product Table 64. Daiichi Sankyo Company Revenue in IV and Oral Iron Drugs Business (2017-2022) & (US$ Million) Table 65. Daiichi Sankyo Company Recent Developments Table 66. Vifor Pharma Company Details Table 67. Vifor Pharma Business Overview Table 68. Vifor Pharma IV and Oral Iron Drugs Product Table 69. Vifor Pharma Revenue in IV and Oral Iron Drugs Business (2017-2022) & (US$ Million) Table 70. Vifor Pharma Recent Developments Table 71. Akebia Therapeutics Company Details Table 72. Akebia Therapeutics Business Overview Table 73. Akebia Therapeutics IV and Oral Iron Drugs Product Table 74. Akebia Therapeutics Revenue in IV and Oral Iron Drugs Business (2017-2022) & (US$ Million) Table 75. Akebia Therapeutics Recent Developments Table 76. Allergan Company Details Table 77. Allergan Business Overview Table 78. Allergan IV and Oral Iron Drugs Product Table 79. Allergan Revenue in IV and Oral Iron Drugs Business (2017-2022) & (US$ Million) Table 80. Allergan Recent Developments Table 81. AMAG Pharmaceuticals Company Details Table 82. AMAG Pharmaceuticals Business Overview Table 83. AMAG Pharmaceuticals IV and Oral Iron Drugs Product Table 84. AMAG Pharmaceuticals Revenue in IV and Oral Iron Drugs Business (2017-2022) & (US$ Million) Table 85. AMAG Pharmaceuticals Recent Developments Table 86. AOP Orphan Pharmaceuticals Company Details Table 87. AOP Orphan Pharmaceuticals Business Overview Table 88. AOP Orphan Pharmaceuticals IV and Oral Iron Drugs Product Table 89. AOP Orphan Pharmaceuticals Revenue in IV and Oral Iron Drugs Business (2017-2022) & (US$ Million) Table 90. AOP Orphan Pharmaceuticals Recent Developments Table 91. Pharmacosmos Company Details Table 92. Pharmacosmos Business Overview Table 93. Pharmacosmos IV and Oral Iron Drugs Product Table 94. Pharmacosmos Revenue in IV and Oral Iron Drugs Business (2017-2022) & (US$ Million) Table 95. Pharmacosmos Recent Developments Table 96. Sanofi Company Details Table 97. Sanofi Business Overview Table 98. Sanofi IV and Oral Iron Drugs Product Table 99. Sanofi Revenue in IV and Oral Iron Drugs Business (2017-2022) & (US$ Million) Table 100. Sanofi Recent Developments Table 101. Shield Therapeutics Company Details Table 102. Shield Therapeutics Business Overview Table 103. Shield Therapeutics IV and Oral Iron Drugs Product Table 104. Shield Therapeutics Revenue in IV and Oral Iron Drugs Business (2017-2022) & (US$ Million) Table 105. Shield Therapeutics Recent Developments Table 106. AZAD Pharma Company Details Table 107. AZAD Pharma Business Overview Table 108. AZAD Pharma IV and Oral Iron Drugs Product Table 109. AZAD Pharma Revenue in IV and Oral Iron Drugs Business (2017-2022) & (US$ Million) Table 110. AZAD Pharma Recent Developments Table 111. Cirondrugs Company Details Table 112. Cirondrugs Business Overview Table 113. Cirondrugs IV and Oral Iron Drugs Product Table 114. Cirondrugs Revenue in IV and Oral Iron Drugs Business (2017-2022) & (US$ Million) Table 115. Cirondrugs Recent Developments Table 116. MEDICE Company Details Table 117. MEDICE Business Overview Table 118. MEDICE IV and Oral Iron Drugs Product Table 119. MEDICE Revenue in IV and Oral Iron Drugs Business (2017-2022) & (US$ Million) Table 120. MEDICE Recent Developments Table 121. Pfizer Company Details Table 122. Pfizer Business Overview Table 123. Pfizer IV and Oral Iron Drugs Product Table 124. Pfizer Revenue in IV and Oral Iron Drugs Business (2017-2022) & (US$ Million) Table 125. Pfizer Recent Developments Table 126. Salveo Lifecare Company Details Table 127. Salveo Lifecare Business Overview Table 128. Salveo Lifecare IV and Oral Iron Drugs Product Table 129. Salveo Lifecare Revenue in IV and Oral Iron Drugs Business (2017-2022) & (US$ Million) Table 130. Salveo Lifecare Recent Developments Table 131. Sunny Pharmaceutical Company Details Table 132. Sunny Pharmaceutical Business Overview Table 133. Sunny Pharmaceutical IV and Oral Iron Drugs Product Table 134. Sunny Pharmaceutical Revenue in IV and Oral Iron Drugs Business (2017-2022) & (US$ Million) Table 135. Sunny Pharmaceutical Recent Developments Table 136. Research Programs/Design for This Report Table 137. Key Data Information from Secondary Sources Table 138. Key Data Information from Primary Sources List of Figures Figure 1. Global IV and Oral Iron Drugs Market Share by Type: 2021 VS 2028 Figure 2. Oral Iron Drug Features Figure 3. IVIron Drugs Features Figure 4. Global IV and Oral Iron Drugs Market Share by Application: 2021 VS 2028 Figure 5. Nephrology Case Studies Figure 6. OBGYN Case Studies Figure 7. Surgeries Case Studies Figure 8. Gastroenterology Case Studies Figure 9. Oncology Case Studies Figure 10. Heart failure (HF) Case Studies Figure 11. IV and Oral Iron Drugs Report Years Considered Figure 12. Global IV and Oral Iron Drugs Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 13. Global IV and Oral Iron Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global IV and Oral Iron Drugs Market Share by Region: 2021 VS 2028 Figure 15. Global IV and Oral Iron Drugs Market Share by Players in 2021 Figure 16. Global Top IV and Oral Iron Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IV and Oral Iron Drugs as of 2021) Figure 17. The Top 10 and 5 Players Market Share by IV and Oral Iron Drugs Revenue in 2021 Figure 18. North America IV and Oral Iron Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 19. North America IV and Oral Iron Drugs Market Size Market Share by Type (2017-2028) Figure 20. North America IV and Oral Iron Drugs Market Size Market Share by Application (2017-2028) Figure 21. North America IV and Oral Iron Drugs Market Size Share by Country (2017-2028) Figure 22. United States IV and Oral Iron Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Canada IV and Oral Iron Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Europe IV and Oral Iron Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 25. Europe IV and Oral Iron Drugs Market Size Market Share by Type (2017-2028) Figure 26. Europe IV and Oral Iron Drugs Market Size Market Share by Application (2017-2028) Figure 27. Europe IV and Oral Iron Drugs Market Size Share by Country (2017-2028) Figure 28. Germany IV and Oral Iron Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. France IV and Oral Iron Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. U.K. IV and Oral Iron Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Italy IV and Oral Iron Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Russia IV and Oral Iron Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Nordic Countries IV and Oral Iron Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Asia-Pacific IV and Oral Iron Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 35. Asia Pacific IV and Oral Iron Drugs Market Size Market Share by Type (2017-2028) Figure 36. Asia Pacific IV and Oral Iron Drugs Market Size Market Share by Application (2017-2028) Figure 37. Asia Pacific IV and Oral Iron Drugs Market Size Share by Region (2017-2028) Figure 38. China IV and Oral Iron Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Japan IV and Oral Iron Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. South Korea IV and Oral Iron Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Southeast Asia IV and Oral Iron Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. India IV and Oral Iron Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Australia IV and Oral Iron Drugs Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 44. Latin America IV and Oral Iron Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 45. Latin America IV and Oral Iron Drugs Market Size Market Share by Type (2017-2028) Figure 46. Latin America IV and Oral Iron Drugs Market Size Market Share by Application (2017-2028) Figure 47. Latin America IV and Oral Iron Drugs Market Size Share by Country (2017-2028) Figure 48. Mexico IV and Oral Iron Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 49. Brazil IV and Oral Iron Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 50. Middle East & Africa IV and Oral Iron Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 51. Middle East and Africa IV and Oral Iron Drugs Market Size Market Share by Type (2017-2028) Figure 52. Middle East and Africa IV and Oral Iron Drugs Market Size Market Share by Application (2017-2028) Figure 53. Middle East and Africa IV and Oral Iron Drugs Market Size Share by Country (2017-2028) Figure 54. Turkey IV and Oral Iron Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. Saudi Arabia IV and Oral Iron Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. UAE IV and Oral Iron Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 57. Daiichi Sankyo Company Revenue Growth Rate in IV and Oral Iron Drugs Business (2017-2022) Figure 58. Vifor Pharma Revenue Growth Rate in IV and Oral Iron Drugs Business (2017-2022) Figure 59. Akebia Therapeutics Revenue Growth Rate in IV and Oral Iron Drugs Business (2017-2022) Figure 60. Allergan Revenue Growth Rate in IV and Oral Iron Drugs Business (2017-2022) Figure 61. AMAG Pharmaceuticals Revenue Growth Rate in IV and Oral Iron Drugs Business (2017-2022) Figure 62. AOP Orphan Pharmaceuticals Revenue Growth Rate in IV and Oral Iron Drugs Business (2017-2022) Figure 63. Pharmacosmos Revenue Growth Rate in IV and Oral Iron Drugs Business (2017-2022) Figure 64. Sanofi Revenue Growth Rate in IV and Oral Iron Drugs Business (2017-2022) Figure 65. Shield Therapeutics Revenue Growth Rate in IV and Oral Iron Drugs Business (2017-2022) Figure 66. AZAD Pharma Revenue Growth Rate in IV and Oral Iron Drugs Business (2017-2022) Figure 67. Cirondrugs Revenue Growth Rate in IV and Oral Iron Drugs Business (2017-2022) Figure 68. MEDICE Revenue Growth Rate in IV and Oral Iron Drugs Business (2017-2022) Figure 69. Pfizer Revenue Growth Rate in IV and Oral Iron Drugs Business (2017-2022) Figure 70. Salveo Lifecare Revenue Growth Rate in IV and Oral Iron Drugs Business (2017-2022) Figure 71. Sunny Pharmaceutical Revenue Growth Rate in IV and Oral Iron Drugs Business (2017-2022) Figure 72. Bottom-up and Top-down Approaches for This Report Figure 73. Data Triangulation Figure 74. Key Executives Interviewed

Daiichi Sankyo Company Vifor Pharma Akebia Therapeutics Allergan AMAG Pharmaceuticals AOP Orphan Pharmaceuticals Pharmacosmos Sanofi Shield Therapeutics AZAD Pharma Cirondrugs MEDICE Pfizer Salveo Lifecare Sunny Pharmaceutical